We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
AGCO Corp's (AGCO) Q4 Earnings & Sales Top Estimates, Up Y/Y
Read MoreHide Full Article
AGCO Corporation (AGCO - Free Report) delivered fourth-quarter 2020 adjusted earnings per share of $1.54, up 39% year over year. The reported figure beat the Zacks Consensus Estimate of $1.08 per share. The company’s quarterly results reflect sales growth and margin expansion across all segments.
Revenues increased 7.5% year over year to $2,717 million during the December-end quarter. The top-line figure also beat the Zacks Consensus Estimate of $2,493 million. Excluding the favorable currency-translation impact of 1.4%, net sales were up 6.7% year over year.
Operational Update
Cost of sales grew 6.1% year over year to $2,122 million in the fourth quarter. Gross profit was up 13.7% year over year to $596 million during the reported quarter. Gross margin came in at 22% compared with the prior-year period’s 20%.
Selling, general and administrative expenses flared up to $283 million from the year-ago quarter’s $272 million. Adjusted income from operations surged 44.3% year over year to $192 million. Consequently, operating margin came in at 7% compared with the year-earlier quarter’s 5%.
AGCO Corporation Price, Consensus and EPS Surprise
Sales in the North America segment were down 10.2% year over year to $485 million during the October-December period. The segment reported an operating income of $9.8 million compared with the prior-year quarter’s $7.1 million.
Sales in the South America segment climbed 21.1% year over year to $268 million. The segment reported an operating profit of $16 million, as against the prior-year quarter’s operating loss of $18.2 million.
The EME (Europe/Middle East) segment’s sales came in at $1,723 million compared with the $1,515 million recorded in the year-ago period. The EME’s operating income was up 12.3% year over year to $205 million.
Sales in the Asia/Pacific segment were up 2.1% year on year to $242 million. The segment reported an operating profit of $26 million compared with the year-ago quarter’s $22 million.
Financial Update
AGCO reported cash and cash equivalents of $1,119 million as of Dec 31, 2020, up from the $433 million recorded as of Dec 31, 2019. The company generated $897 million of cash from operating activities in 2020 compared with the $696 million recorded in 2019.
2020 Results
AGCO reported adjusted earnings per share of $5.61 in 2020, up 26.3% from the prior-year reported figure of $4.44. Earnings also beat the Zacks Consensus Estimate of $5.14.
Sales were up 1.2% year over year to $9.15 billion from the prior-year figure of $9.04 billion. The top line also surpassed the Zacks Consensus Estimate of $8.93 billion.
Guidance
The company expects net sales for the ongoing year to lie between $10.2 billion and $10.4 billion, suggesting improved sales volumes, pricing and positive impacts of foreign-currency translation. Gross and operating margins are projected to be higher than 2020 levels, reflecting higher sales and production volumes as well as margin-improvement plans. These improvements will support AGCO’s investments in precision agriculture and digital initiatives. Considering these, AGCO expects adjusted earnings per share for the current year in the range of $7.00 to $7.25.
Higher commodity prices and improved farmer sentiment are anticipated to drive North American industry sales in the current year. Healthy crop production and favorable exchange rates in Brazil and Argentina are supporting positive economics in South America, while strong replacement demand will result in higher industry sales compared with 2020. Increasing demand for commodities, driven by the growing world population, rising emerging market protein consumption and biofuel use, will likely strengthen prospects of the agricultural industry.
Share Price Performance
Over the past year, AGCO’s stock has gained 75.3%, outperforming the industry’s growth of 75.2%.
Some other top-ranked stocks in the industrial products sector are Apogee Enterprises, Inc. (APOG - Free Report) , AptarGroup Inc. (ATR - Free Report) and Crown Holdings, Inc. (CCK - Free Report) , each carrying a Zacks Rank #2 (Buy) at present.
Apogee has an expected earnings growth rate of 1.26% for the current fiscal year. The company’s shares have gained around 10.7% in the past year.
AptarGroup has a projected earnings growth rate of 14.4% for the current fiscal year. The stock has appreciated around 17% in a year’s time.
Crown Holdings has an estimated earnings growth rate of 11.7% for the current fiscal year. The company’s shares have rallied nearly 21% over the past year.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
Image: Bigstock
AGCO Corp's (AGCO) Q4 Earnings & Sales Top Estimates, Up Y/Y
AGCO Corporation (AGCO - Free Report) delivered fourth-quarter 2020 adjusted earnings per share of $1.54, up 39% year over year. The reported figure beat the Zacks Consensus Estimate of $1.08 per share. The company’s quarterly results reflect sales growth and margin expansion across all segments.
Revenues increased 7.5% year over year to $2,717 million during the December-end quarter. The top-line figure also beat the Zacks Consensus Estimate of $2,493 million. Excluding the favorable currency-translation impact of 1.4%, net sales were up 6.7% year over year.
Operational Update
Cost of sales grew 6.1% year over year to $2,122 million in the fourth quarter. Gross profit was up 13.7% year over year to $596 million during the reported quarter. Gross margin came in at 22% compared with the prior-year period’s 20%.
Selling, general and administrative expenses flared up to $283 million from the year-ago quarter’s $272 million. Adjusted income from operations surged 44.3% year over year to $192 million. Consequently, operating margin came in at 7% compared with the year-earlier quarter’s 5%.
AGCO Corporation Price, Consensus and EPS Surprise
AGCO Corporation price-consensus-eps-surprise-chart | AGCO Corporation Quote
Segment Performance
Sales in the North America segment were down 10.2% year over year to $485 million during the October-December period. The segment reported an operating income of $9.8 million compared with the prior-year quarter’s $7.1 million.
Sales in the South America segment climbed 21.1% year over year to $268 million. The segment reported an operating profit of $16 million, as against the prior-year quarter’s operating loss of $18.2 million.
The EME (Europe/Middle East) segment’s sales came in at $1,723 million compared with the $1,515 million recorded in the year-ago period. The EME’s operating income was up 12.3% year over year to $205 million.
Sales in the Asia/Pacific segment were up 2.1% year on year to $242 million. The segment reported an operating profit of $26 million compared with the year-ago quarter’s $22 million.
Financial Update
AGCO reported cash and cash equivalents of $1,119 million as of Dec 31, 2020, up from the $433 million recorded as of Dec 31, 2019. The company generated $897 million of cash from operating activities in 2020 compared with the $696 million recorded in 2019.
2020 Results
AGCO reported adjusted earnings per share of $5.61 in 2020, up 26.3% from the prior-year reported figure of $4.44. Earnings also beat the Zacks Consensus Estimate of $5.14.
Sales were up 1.2% year over year to $9.15 billion from the prior-year figure of $9.04 billion. The top line also surpassed the Zacks Consensus Estimate of $8.93 billion.
Guidance
The company expects net sales for the ongoing year to lie between $10.2 billion and $10.4 billion, suggesting improved sales volumes, pricing and positive impacts of foreign-currency translation. Gross and operating margins are projected to be higher than 2020 levels, reflecting higher sales and production volumes as well as margin-improvement plans. These improvements will support AGCO’s investments in precision agriculture and digital initiatives. Considering these, AGCO expects adjusted earnings per share for the current year in the range of $7.00 to $7.25.
Higher commodity prices and improved farmer sentiment are anticipated to drive North American industry sales in the current year. Healthy crop production and favorable exchange rates in Brazil and Argentina are supporting positive economics in South America, while strong replacement demand will result in higher industry sales compared with 2020. Increasing demand for commodities, driven by the growing world population, rising emerging market protein consumption and biofuel use, will likely strengthen prospects of the agricultural industry.
Share Price Performance
Over the past year, AGCO’s stock has gained 75.3%, outperforming the industry’s growth of 75.2%.
Zacks Rank and Other Stocks to Consider
AGCO currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Some other top-ranked stocks in the industrial products sector are Apogee Enterprises, Inc. (APOG - Free Report) , AptarGroup Inc. (ATR - Free Report) and Crown Holdings, Inc. (CCK - Free Report) , each carrying a Zacks Rank #2 (Buy) at present.
Apogee has an expected earnings growth rate of 1.26% for the current fiscal year. The company’s shares have gained around 10.7% in the past year.
AptarGroup has a projected earnings growth rate of 14.4% for the current fiscal year. The stock has appreciated around 17% in a year’s time.
Crown Holdings has an estimated earnings growth rate of 11.7% for the current fiscal year. The company’s shares have rallied nearly 21% over the past year.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>